Literature DB >> 31680042

Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.

Hanne V Olesen1, Pavel Drevinek2, Vincent A Gulmans3, Elpis Hatziagorou4, Andreas Jung5, Meir Mei-Zahav6, Natasa Stojnic7, Muriel Thomas8, Anna Zolin9.   

Abstract

BACKGROUND: Cystic fibrosis related diabetes (CFRD) has implications for morbidity and mortality with several risk factors identified. We studied the epidemiology of CFRD in the large dataset of the European Cystic Fibrosis Society Patient registry.
METHODS: Data on CF patients were investigated for the prevalence of CFRD as well as for any association with suggested risk factors and effects.
RESULTS: CFRD increased by approximately ten percentage points every decade from ten years of age. Prevalence was higher in females in the younger age groups. CFRD was associated with severe CF genotypes (OR = 3.11, 95%CI: 2.77-3.48), pancreatic insufficiency (OR = 1.46, 95%CI: 1.39-1.53) and female gender (OR = 1.28, 95%CI: 1.21-1.34). Patients with CFRD had higher odds of being chronically infected with Pseudomonas aeruginosa, Burkholderia cepacia complex and Stenotrophomonas maltophilia than patients without CFRD, higher odds of having FEV1% of predicted <40% (OR = 1.82, 95%CI: 1.70-1.94) and higher odds of having BMI SDS ≤-2 than patients without CFRD (OR = 1.24, 95%CI: 1.15-1.34).
CONCLUSIONS: Severe genotype, pancreatic insufficiency and female gender remain considerable intrinsic risk factors for early acquisition of CFRD. CFRD is associated with infections, lower lung function and poor nutritional status. Early diagnosis and aggressive treatment of CFRD are more important than ever with increasing life span.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Body mass index; Cystic fibrosis; Diabetes; Gender; Lung function

Mesh:

Substances:

Year:  2019        PMID: 31680042     DOI: 10.1016/j.jcf.2019.10.009

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  11 in total

1.  Clinical practice versus guidelines for the screening of cystic fibrosis-related diabetes: A French survey from the 47 centers.

Authors:  Laurence Weiss; Olivia Ronsin; Quitterie Reynaud; Michel Abely; Laurent Mely; Pierre-Régis Burgel; Jacques Beltrand; Laurence Kessler
Journal:  J Clin Transl Endocrinol       Date:  2022-04-04

Review 2.  Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors.

Authors:  Fernanda Iafusco; Giovanna Maione; Francesco Maria Rosanio; Enza Mozzillo; Adriana Franzese; Nadia Tinto
Journal:  Diagnostics (Basel)       Date:  2021-03-22

3.  Deoxyhypusine synthase, an essential enzyme for hypusine biosynthesis, is required for proper exocrine pancreas development.

Authors:  Leah R Padgett; Morgan A Robertson; Emily K Anderson-Baucum; Craig T Connors; Wenting Wu; Raghavendra G Mirmira; Teresa L Mastracci
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

4.  Cystic fibrosis related diabetes (CFRD) prognosis.

Authors:  Zahrae Sandouk; Farah Khan; Swapnil Khare; Antoinette Moran
Journal:  J Clin Transl Endocrinol       Date:  2021-11-19

5.  Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis.

Authors:  Swapnil Khare; Marisa Desimone; Nader Kasim; Christine L Chan
Journal:  J Clin Transl Endocrinol       Date:  2021-12-07

Review 6.  The Potential Causes of Cystic Fibrosis-Related Diabetes.

Authors:  Lise Coderre; Lyna Debieche; Joëlle Plourde; Rémi Rabasa-Lhoret; Sylvie Lesage
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

7.  Cystic Fibrosis-Related Diabetes in Poland.

Authors:  Marta Rachel; Marek Biesiadecki; Sabina Galiniak
Journal:  Int J Environ Res Public Health       Date:  2022-03-29       Impact factor: 3.390

8.  Oral Glucose Tolerance Test in Patients with Cystic Fibrosis Compared to the Overweight and Obese: A Different Approach in Understanding the Results.

Authors:  Mirela Mogoi; Liviu Laurentiu Pop; Mihaela Dediu; Ioana Mihaiela Ciuca
Journal:  Children (Basel)       Date:  2022-04-08

9.  Continuous Glucose Monitoring as a Valuable Tool in the Early Detection of Diabetes Related to Cystic Fibrosis.

Authors:  Bojana Gojsina; Predrag Minic; Sladjana Todorovic; Ivan Soldatovic; Aleksandar Sovtic
Journal:  Front Pediatr       Date:  2021-07-09       Impact factor: 3.418

Review 10.  Pancreatic complications in children with cystic fibrosis.

Authors:  Zachary M Sellers
Journal:  Curr Opin Pediatr       Date:  2020-10       Impact factor: 2.893

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.